Cuorips News

Cuorips: Notice of provision of cardiomyocyte sheets for treatment of dilated heart disease using human iPS cell-derived cardiomyocyte sheets

May 29 01:30

Cuorips: About some reports about our company

May 26 19:00

Cuorips: Announcement of the launch of a cell mass manufacturing value chain consortium that enables the development and practical application of next-generation regenerative medicine modalities

May 24 02:00

Cuorips: Notice regarding changes in officers

May 21 21:30

Cuorips: Notice regarding differences between individual results and previous fiscal year results

May 13 01:30

Cuorips: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)

May 13 01:30

Cuorips: Notice of commencement of joint development related to a cell mass manufacturing system based at Nakanoshima Qross

Apr 25 01:30

Cuorips: Correction Report (Mass Ownership Report/Change Report)

Apr 21 21:55

Qualips: Change Report

Apr 11 01:36

Qualips: Mass Ownership Report

Mar 7 22:42

Qualips: Corrected Report (Mass Ownership Report/Change Report)

Feb 28 01:14

Qualips: Quarterly Report - 8th Quarter 3rd Quarter (2023/10/01 - 2023/12/31)

Feb 13 00:36

Qualips: Confirmation

Feb 13 00:36

Cuorips: Notice regarding publication of consolidated earnings forecasts due to the transition to consolidated financial results

Feb 13 00:30

Cuorips: Summary of Financial Results for the 3rd Quarter Ending March 31, 2024 [Japanese GAAP] (Consolidated)

Feb 13 00:30

Cuorips: Change Report

Feb 2 00:28

Cuorips: Change Report

Jan 24 00:35

Cuorips: Change Report

Jan 18 00:01

Cuorips: Change Report

Jan 11 01:07

Cuorips: Change Report

Nov 21, 2023 01:01